Search Results

You are looking at 21 - 29 of 29 items for :

  • "Beta blockers" x
  • Refine by Access: Content accessible to me x
Clear All

oxygen, aspirin, beta-blockers, and other inhibitors of platelet aggregation and coagulation. Thrombolytic therapy should be avoided in IE-associated acute coronary syndrome because of the risk of cerebral and systemic hemorrhage. The risk of bleeding may

Open access

inhibitor or beta blocker on glomerular structural changes in young microalbuminuric patients with type I (insulin-dependent) diabetes mellitus. Diabetologia, 1999, 42 , 589–595. Bangstad H. J

Open access

) . Fig. 1. Chart showing type of in-stent restenosis All the study patients were receiving beta blockers, of which metaprolol (31.3% vs. 77.5%) intake was higher in controls. Nitrate intake was

Open access
Interventional Medicine and Applied Science
Authors: Tejaswi Jadhav, Hashir Kareem, Krishnananda Nayak, Umesh Pai, Tom Devasia, and Ramachandran Padmakumar

congenital heart disease were excluded. Various echocardiographic parameters were assessed for each patient 1 day prior to surgery, 3–5 days after surgery, and at 1-month follow-up. Medications including angiotensin-converting enzyme inhibitor and beta-blockers

Open access

.0) Angiotensin-converting enzyme inhibitor/angiotensin receptor blocker, n (%) 33 (89.2) Beta blocker, n (%) 32 (86

Open access

the literature. This approach allowed to balance the patients' expectations towards the treatment final outcome. Indeed, Patient 1 started an off-label pharmacological treatment with the beta-blocker propranolol before the rTMS protocol obtaining an

Open access
Interventional Medicine and Applied Science
Authors: András Mihály Boros, Péter Perge, Klaudia Vivien Nagy, Astrid Apor, Zsolt Bagyura, Endre Zima, Levente Molnár, Tamás Tahin, Dávid Becker, László Gellér, Béla Merkely, and Gábor Széplaki

) Beta-blocker 115 (89) Mineralocorticoid receptor inhibitor 92 (71) Loop diuretics 101 (78

Open access

, and because it helps us to propose with the due caution the PDE5i, in particular sildenafil, as candidate drugs ready to be inserted into the group of drugs (ACE inhibitors, beta blockers, aldosterone receptor antagonists) that on the basis of

Open access

blockers. In combination with other drugs (diuretics, beta blockers, …) it is used to treat cardiovascular diseases: hypertension, angina pectoris, etc [ 14 ]. On the market, this drug is quite common, most often in the form of tablets in doses of 5 mg and

Open access